Overview

Open-label, Multicenter, multinAtionaL, inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients

Status:
Recruiting

Trial end date:
2024-05-03

Target enrollment:

Participant gender:

Summary

Open-label, inteRventional clinical Trial to assess EffIcacy and safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients.

Phase:

Phase 4

Details

Lead Sponsor:

Menarini International Operations Luxembourg SA

Treatments:

Nebivolol
Ramipril